360 ONE Q1 FY27 PAT up 14.8% at Rs 330 Cr; Board approves ESAR Scheme 2026

Revenue Growth 20pctEmphasis Of MatterResults View source PDF Explain this filing

360ONE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.7%Reaction day

₹1085.00

prior close

₹1108.30

announcement price

After-mkt

timing

Nifty Midcap 150market-0.4%+3.1% vs market

Stockbroking & Allied peers, median of 37sector-0.4%+3.0% vs sector

On the reaction day the stock moved 3.1 pts more than Nifty Midcap 150 and 3.0 pts more than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.2

10m

-0.7

15m

+0.4

30m

+1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.7-0.4+3.1-0.4+3.0

Next day

+3.5+0.1+3.4-0.4+3.9

+3.1+0.5+2.6-0.9+4.0

+0.6-0.6+1.2-1.3+1.9

-0.2-1.5+1.4-1.6+1.4

+1.5-1.6+3.2-1.8+3.4

+3.8-0.6+4.3-3.2+7.0

15d

+7.6+1.3+6.3-3.6+11.2

+8.1+1.7+6.4-2.6+10.7

-2.3-2.1-0.2-2.0-0.3

-2.8-6.8+4.0-6.2+3.4

UpDownMarket · Nifty Midcap 150Sector · Stockbroking & Allied peers, median of 37Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

360 ONE WAM reported Q1 FY27 consolidated PAT of Rs 330 Cr, up 14.8% YoY. Total revenue rose 20% YoY to Rs 870 Cr, with ARR revenue up 20.3% to Rs 614 Cr. ARR AUM grew 19% to Rs 3.42 lakh Cr; overall AUM stood at Rs 7.77 lakh Cr. Board approved ESAR Scheme 2026 covering up to 11.2 lakh shares (about 0.28% of capital). Income Tax demand of Rs 336 Cr treated as contingent liability; appeal filed. Interim dividend of Rs 6 per share paid.

Likely market impact

Strong revenue growth and steady PAT rise are positive. Tax demand remains a contingent risk; new ESAR scheme may cause minor future dilution.